NeurAxis, Inc.

AMEX:NRXS

Biotechnology

Healthcare
$4.87 +4.25%

+$0.29 today

Market cap
$69.12M
Beta
1.41
P/E (TTM)
-10.5
EPS (TTM)
-$0.67
52W Low $2.20High $9.33

Volume 0.23M

Average 0.18M

Income Statement

Follow revenue through to earnings.

Revenue

$3.57M

FY 2025 · Annual

+32.9% YoY

Operating Income

-$7.83M

FY 2025 · Annual

Net Income

-$7.80M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.72M2.68M2.46M2.69M3.57M
Cost of Revenue467.66K297.06K303.35K362K562.92K
Gross Profit2.25M2.39M2.16M2.32M3.01M
Gross Margin82.8%88.9%87.7%86.5%84.2%
Research & Development203.41K225.61K169.32K206.11K493.61K
Selling, General & Admin5.02M5.53M8.65M9.27M10.34M
Operating Expenses5.22M5.76M8.82M9.48M10.84M
Depreciation & Amortization36.71K37.13K40.73K37.83K59.5K
EBITDA(2.95M)(4.33M)(9.23M)(7.9M)(7.67M)
EBITDA Margin-108.6%-161.1%-375.1%-294.2%-214.8%
Operating Income(2.97M)(3.37M)(6.66M)(7.16M)(7.83M)
Operating Margin-109.1%-125.6%-270.9%-266.5%-219.4%
Interest Income0(2.32M)(2.77K)00
Interest Expense36.93K417.6K5.36M300.72K73.97K
Other Income / Expenses(58K)(1.41M)(7.96M)(1.08M)29.35K
Income Before Tax(3.03M)(4.78M)(14.63M)(8.24M)(7.8M)
Pre-Tax Margin-111.3%-178.0%-594.6%-306.8%-218.5%
Income Tax Expense00000
Net Income(3.03M)(4.78M)(14.63M)(8.24M)(7.8M)
Net Margin-111.3%-178.0%-594.6%-306.8%-218.5%
EPS (Basic)(0.62)(0.57)(2.32)(1.22)(0.95)
EPS (Diluted)(0.62)(0.78)(2.32)(1.22)(0.95)
Weighted Avg Shares5.38M8.41M6.3M6.92M9.08M
Weighted Avg Shares (Diluted)5.38M8.41M6.3M6.92M9.08M

NRXS Earnings Waterfall · TTM

AMEX:NRXS · Revenue to Net Income

Key Ratios

EPS$-0.80
Gross Margin84.7%
Net Margin-184.2%
P/E Ratio-6.0
P/S Ratio38.4

Analysis

$4.3M of revenue converted into -$7.3M of net income for the selected period. Gross margin is 84.7% and net margin is -184.2%, showing how much revenue survives after costs and taxes. EPS is $-0.80, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 10, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportOct 14, 2026
4Statement of changes in beneficial ownershipOct 8, 2026
4Statement of changes in beneficial ownershipOct 8, 2026

How much revenue does NRXS generate?

NeurAxis, Inc. (NRXS) reported $3.57M of revenue in fiscal 2025.

Is NRXS profitable?

NeurAxis, Inc. (NRXS) reported -$7.80M of net income, with a net margin of -218.5%.